Abnormal electrocardiographic findings in athletes: Recognising changes suggestive of cardiomyopathy

British Journal of Sports Medicine

Volumn 47, Issue 3, 2013, Pages 137-152

  Drezner, Jonathan A ^a   Ashley, Euan ^b   Baggish, Aaron L ^c   Börjesson, Mats ^d   Corrado, Domenico ^e   Owens, David S ^a   Patel, Akash ^f   Pelliccia, Antonio ^g   Vetter, Victoria L ^f   Ackerman, Michael J ^h   Anderson, Jeff ⁱ   Asplund, Chad A ^j   Cannon, Bryan C ^h   DiFiori, John ^k   Fischbach, Peter ^l   Froelicher, Victor ^b   Harmon, Kimberly G ^a   Heidbuchel, Hein ^m   Marek, Joseph ⁿ   Paul, Stephen ^o   Prutkin, Jordan M ^a   Salerno, Jack C ^p   Schmied, Christian M ^q   Sharma, Sanjay ^r   Stein, Ricardo ^s   Wilson, Mathew ^t   more..

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF PADOVA   (Italy)

^f CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^g Institute of Sports Medicine and Science   (Italy)

^h MAYO CLINIC   (United States)

ⁱ UNIVERSITY OF CONNECTICUT   (United States)

^j EISENHOWER ARMY MEDICAL CENTER   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m UNIVERSITY OF LEUVEN   (Belgium)

ⁿ Midwest Heart Foundation   (United States)

^o UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^p SEATTLE CHILDREN S HOSPITAL   (United States)

^q UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^r ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^s HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^t ASPETAR ORTHOPAEDIC AND SPORTS MEDICINE HOSPITAL   (Qatar)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOMYOPATHY; DIFFERENTIAL DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ETHNOLOGY; EXERCISE INDUCED CARDIOMEGALY; HEART ARRHYTHMIA; HUMAN; NEGRO; PHYSIOLOGY; REVIEW; SPORT; SUDDEN CARDIAC DEATH;

AFRICAN CONTINENTAL ANCESTRY GROUP; ARRHYTHMIAS, CARDIAC; CARDIOMEGALY, EXERCISE-INDUCED; CARDIOMYOPATHIES; DEATH, SUDDEN, CARDIAC; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HUMANS; SPORTS;

MLCS; MLOWN;

EID: 84872353810     PISSN: 03063674     EISSN: 14730480     Source Type: Journal    
DOI: 10.1136/bjsports-2012-092069     Document Type: Article

References (92)

1. Maron BJ, Doerer JJ, Haas TS, et al. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation 2009;119:1085-92.
2. Maron BJ. Sudden death in young athletes. N Engl J Med 2003;349:1064-75.
3. Corrado D, Basso C, Schiavon M, et al. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 1998;339:364-9.
4. Corrado D, Biffi A, Basso C, et al. 12-Lead ECG in the athlete: physiological versus pathological abnormalities. Br J Sports Med 2009;43:669-76.
5. Corrado D, Pelliccia A, Heidbuchel H, et al. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J 2010;31:243-59.
6. Uberoi A, Stein R, Perez MV, et al. Interpretation of the electrocardiogram of young athletes. Circulation 2011;124:746-57.
7. Williams ES, Owens DS, Drezner JA, et al. Electrocardiogram interpretation in the athlete. Herzschrittmacherther Elektrophysiol 2012;23:65-71.
8. Drezner J. Standardised criteria for ECG interpretation in athletes: a practical tool. Br J Sports Med 2012;46(Suppl I): i6-8.
9. Marek J, Bufalino V, Davis J, et al. Feasibility and findings of large-scale electrocardiographic screening in young adults: data from 32 561 subjects. Heart Rhythm 2011;8:1555-9.
10. Drezner JA, Ackerman MJ, Anderson J, et al. Electrocardiographic interpretation in athletes: the 'seattle criteria'. Br J Sports Med 2013;47.
11. Drezner JA, Fischbach P, Foelicher V, et al. Normal electrocardiographic findings: recognizing physiologic adaptations in athletes. Br J Sports Med 2013;47.
12. Maron BJ. Hypertrophic cardiomyopathy. Lancet 1997;350:127-33.
13. Maron BJ, Shirani J, Poliac LC, et al. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA 1996;276:199-204.
14. Basavarajaiah S, Wilson M, Whyte G, et al. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening. J Am Coll Cardiol 2008;51:1033-9.
15. de Noronha SV, Sharma S, Papadakis M, et al. Aetiology of sudden cardiac death in athletes in the United Kingdom: a pathological study. Heart 2009;95:1409-14.
16. Eckart RE, Shry EA, Burke AP, et al. Sudden death in young adults an autopsy-based series of a population undergoing active surveillance. J Am Coll Cardiol 2011;58:1254-61.
17. Meyer L, Stubbs B, Fahrenbruch C, et al. Incidence, causes, and survival trends from cardiovascular-related sudden cardiac arrest in children and young adults 0 to 35 years of age: a 30-year review. Circulation 2012;126:1363-72.
18. Maron BJ. Distinguishing hypertrophic cardiomyopathy from athlete's heart physiological remodelling: clinical significance, diagnostic strategies and implications for preparticipation screening. Br J Sports Med 2009;43:649-56.
19. Ryan MP, Cleland JG, French JA, et al. The standard electrocardiogram as a screening test for hypertrophic cardiomyopathy. Am J Cardiol 1995;76:689-94.
20. Maron BJ, Roberts WC, Epstein SE. Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation 1982;65:1388-94.
21. Rowin EJ, Maron BJ, Appelbaum E, et al. Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy. Am J Cardiol 2012;110:1027-32.
22. Lakdawala NK, Thune JJ, Maron BJ, et al. Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy. Am J Cardiol 2011;108:1606-13.
23. Papadakis M, Carre F, Kervio G, et al. The prevalence, distribution, and clinical outcomes of electrocardiographic repolarization patterns in male athletes of African/ Afro-Caribbean origin. Eur Heart J 2011;32:2304-13.
24. Papadakis M, Basavarajaiah S, Rawlins J, et al. Prevalence and significance of T-wave inversions in predominantly Caucasian adolescent athletes. Eur Heart J 2009;30:1728-35.
25. Le VV, Wheeler MT, Mandic S, et al. Addition of the electrocardiogram to the preparticipation examination of college athletes. Clin J Sport Med 2010;20: 98-105.
26. Pelliccia A, Maron BJ, Culasso F, et al. Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation 2000;102:278-84.
27. Di Paolo FM, Schmied C, Zerguini YA, et al. The athlete's heart in adolescent Africans: an electrocardiographic and echocardiographic study. J Am Coll Cardiol 2012;59:1029-36.
28. Migliore F, Zorzi A, Michieli P, et al. Prevalence of cardiomyopathy in Italian asymptomatic children with electrocardiographic T-wave inversion at preparticipation screening. Circulation 2012;125:529-38.
29. Konno T, Shimizu M, Ino H, et al. Diagnostic value of abnormal Q waves for identification of preclinical carriers of hypertrophic cardiomyopathy based on a molecular genetic diagnosis. Eur Heart J 2004;25:246-51.
30. Pelliccia A, Culasso F, Di Paolo FM, et al. Prevalence of abnormal electrocardiograms in a large, unselected population undergoing pre-participation cardiovascular screening. Eur Heart J 2007;28:2006-10.
31. Sohaib SM, Payne JR, Shukla R, et al. Electrocardiographic (ECG) criteria for determining left ventricular mass in young healthy men; data from the LARGE Heart study. J Cardiovasc Magn Reson 2009;11:2.
32. Sathanandam S, Zimmerman F, Davis J, et al. Abstract 2484: ECG screening criteria for LVH does not correlate with diagnosis of hypertrophic cardiomyopathy. Circulation 2009;120:S647.
33. Weiner RB, Hutter AM, Wang F, et al. Performance of the 2010 European Society of Cardiology criteria for ECG interpretation in the athlete. Heart 2011;97:1573-7.
34. Gersh BJ, Maron BJ, Bonow RO, et al. ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011;124:e783-831.
35. Maron MS, Maron BJ, Harrigan C, et al. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol 2009;54:220-8.
36. Pelliccia A, Maron MS, Maron BJ. Assessment of left ventricular hypertrophy in a trained athlete: differential diagnosis of physiologic athlete's heart from pathologic hypertrophy. Prog Cardiovasc Dis 2012;54:387-96.
37. Rawlins J, Bhan A, Sharma S. Left ventricular hypertrophy in athletes. Eur J Echocardiogr 2009;10:350-6.
38. Maron BJ. Distinguishing hypertrophic cardiomyopathy from athlete's heart: a clinical problem of increasing magnitude and significance. Heart 2005;91:1380-2.
39. Maron BJ, Wolfson JK, Ciro E, et al. Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy. Am J Cardiol 1983;51:189-94.
40. Thiene G, Nava A, Corrado D, et al. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988;318:129-33.
41. Maron BJ, Niimura H, Casey SA, et al. Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. J Am Coll Cardiol 2001;38:315-21.
42. Maron BJ, Seidman JG, Seidman CE. Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;44:2125-32.
43. Pelliccia A, Di Paolo FM, Quattrini FM, et al. Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med 2008;358:152-61.
44. Basso C, Corrado D, Marcus FI, et al. Arrhythmogenic right ventricular cardiomyopathy. Lancet 2009;373:1289-300.
45. Corrado D, Basso C, Thiene G. Arrhythmogenic right ventricular cardiomyopathy: an update. Heart 2009;95:766-73.
46. Heidbuchel H, Hoogsteen J, Fagard R, et al. High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias. Role of an electrophysiologic study in risk stratification. Eur Heart J 2003;24:1473-80.
47. La Gerche A, Robberecht C, Kuiperi C, et al. Lower than expected desmosomal gene mutation prevalence in endurance athletes with complex ventricular arrhythmias of right ventricular origin. Heart 2010;96:1268-74.
48. Heidbuchel H, Prior DL, Gerche AL. Ventricular arrhythmias associated with long-term endurance sports: what is the evidence? Br J Sports Med 2012;46(Suppl 1):i44-50.
49. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 2010;121:1533-41.
50. Nasir K, Bomma C, Tandri H, et al. Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria. Circulation 2004;110:1527-34.
51. Steriotis AK, Bauce B, Daliento L, et al. Electrocardiographic pattern in arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol 2009;103:1302-8.
52. Protonotarios N, Anastasakis A, Antoniades L, et al. Arrhythmogenic right ventricular cardiomyopathy/dysplasia on the basis of the revised diagnostic criteria in affected families with desmosomal mutations. Eur Heart J 2011;32:1097-104.
53. Kamath GS, Zareba W, Delaney J, et al. Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm 2011;8:256-62.
54. Marcus FI, Zareba W, Calkins H, et al. Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study. Heart Rhythm 2009;6:984-92.
55. Atherton JJ. Screening for left ventricular systolic dysfunction: is imaging a solution? JACC Cardiovasc Imaging 2010;3:421-8.
56. Ammar KA, Jacobsen SJ, Mahoney DW, et al. Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community. Circulation 2007;115:1563-70.
57. Galasko GI, Barnes SC, Collinson P, et al. What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination? Eur Heart J 2006;27:193-200.
58. Wang TJ, Evans JC, Benjamin EJ, et al. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 2003;108:977-82.
59. Baig MK, Goldman JH, Caforio AL, et al. Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease. J Am Coll Cardiol 1998;31:195-201.
60. Grunig E, Tasman JA, Kucherer H, et al. Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol 1998;31:186-94.
61. Mahon NG, Murphy RT, MacRae CA, et al. Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease. Ann Intern Med 2005;143:108-15.
62. Surwicz B, Knilan T, eds. Chou's electrocardiography in clinical practice. Philadelphia: WB Saunders Company, 2001:256-8.
63. Goldberger AL. A specific ECG triad associated with congestive heart failure. Pacing Clin Electrophysiol 1982;5:593-9.
64. Pelliccia A, Culasso F, Di Paolo FM, et al. Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med 1999;130:23-31.
65. Abergel E, Chatellier G, Hagege AA, et al. Serial left ventricular adaptations in world-class professional cyclists: implications for disease screening and follow-up. J Am Coll Cardiol 2004;44:144-9.
66. Paterick TE, Umland MM, Jan MF, et al. Left ventricular noncompaction: a 25-year odyssey. J Am Soc Echocardiogr 2012;25:363-75.
67. Sarma RJ, Chana A, Elkayam U. Left ventricular noncompaction. Prog Cardiovasc Dis 2010;52:264-73.
68. Steffel J, Duru F. Rhythm disorders in isolated left ventricular noncompaction. Ann Med 2012;44:101-8.
69. Chin TK, Perloff JK, Williams RG, et al. Isolated noncompaction of left ventricular myocardium. A study of eight cases. Circulation 1990;82:507-13.
70. Jenni R, Oechslin E, Schneider J, et al. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart 2001;86:666-71.
71. Jacquier A, Thuny F, Jop B, et al. Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction. Eur Heart J 2010;31:1098-104.
72. Petersen SE, Selvanayagam JB, Wiesmann F, et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 2005;46:101-5.
73. Stollberger C, Kopsa W, Tscherney R, et al. Diagnosing left ventricular noncompaction by echocardiography and cardiac magnetic resonance imaging and its dependency on neuromuscular disorders. Clin Cardiol 2008;31:383-7.
74. Kohli SK, Pantazis AA, Shah JS, et al. Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria? Eur Heart J 2008;29:89-95.
75. Steffel J, Kobza R, Oechslin E, et al. Electrocardiographic characteristics at initial diagnosis in patients with isolated left ventricular noncompaction. Am J Cardiol 2009;104:984-9.
76. Corrado D, Basso C, Buja G, et al. Right bundle branch block, right precordial ST-segment elevation, and sudden death in young people. Circulation 2001;103:710-17.
77. Schneider JF, Thomas HE, Kreger BE, et al. Newly acquired right bundle-branch block: the Framingham Study. Ann Intern Med 1980;92:37-44.
78. Brugada J, Brugada R, Antzelevitch C, et al. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002;105:73-8.
79. Steffel J, Kobza R, Namdar M, et al. Electrophysiological findings in patients with isolated left ventricular non-compaction. Europace 2009;11:1193-200.
80. Nelson GS, Curry CW, Wyman BT, et al. Predictors of systolic augmentation from left ventricular preexcitation in patients with dilated cardiomyopathy and intraventricular conduction delay. Circulation 2000;101:2703-9.
81. Xiao HB, Brecker SJ, Gibson DG. Relative effects of left ventricular mass and conduction disturbance on activation in patients with pathological left ventricular hypertrophy. Br Heart J 1994;71:548-53.
82. Baman TS, Lange DC, Ilg KJ, et al. Relationship between burden of premature ventricular complexes and left ventricular function. Heart Rhythm 2010;7:865-9.
83. Braunwald E, Brockenbrough EC, Morrow AG. Hypertrophic subaortic stenosis - a broadened concept. Circulation 1962;26:161-5.
84. Marek JC. Electrocardiography and preparticipation screening of competitive high school athletes. Ann Int Med 2011;153:131-2.
85. Baggish AL, Hutter AM Jr, Wang F, et al. Cardiovascular screening in college athletes with and without electrocardiography: a cross-sectional study. Ann Intern Med 2010;152:269-75.
86. Biffi A, Maron BJ, Verdile L, et al. Impact of physical deconditioning on ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol 2004;44:1053-8.
87. Biffi A, Pelliccia A, Verdile L, et al. Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol 2002;40:446-52.
88. Kim JH, Noseworthy PA, McCarty D, et al. Significance of electrocardiographic right bundle branch block in trained athletes. Am J Cardiol 2011;107:1083-9.
89. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987;107:216-23.
90. Bossone E, Paciocco G, Iarussi D, et al. The prognostic role of the ECG in primary pulmonary hypertension. Chest 2002;121:513-18.
91. Henkens IR, Gan CT, van Wolferen SA, et al. ECG monitoring of treatment response in pulmonary arterial hypertension patients. Chest 2008;134:1250-7.
92. Ahearn GS, Tapson VF, Rebeiz A, et al. Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease. Chest 2002;122:524-7.